What medications can trigger Brugada syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Trigger Brugada Syndrome

Multiple medication classes can trigger or unmask Brugada syndrome, with sodium channel blockers being the most significant risk, and patients should avoid these medications along with certain psychotropic drugs, anesthetics, and other agents listed on www.brugadadrugs.org. 1, 2

Sodium Channel Blockers

These medications pose the highest risk and are most commonly associated with unmasking the Brugada ECG pattern:

  • Class I antiarrhythmics:
    • Flecainide
    • Procainamide
    • Ajmaline (most potent at unmasking Brugada pattern) 3
    • Pilsicainide
    • Propafenone
    • Disopyramide

Psychotropic Medications

  • Tricyclic antidepressants 2, 4
  • Selective serotonin reuptake inhibitors (e.g., fluoxetine) 4
  • Other psychiatric medications:
    • Lithium
    • Trifluoperazine

Calcium Channel Blockers

Certain calcium channel blockers should be avoided in Brugada syndrome patients 2

Beta-Blockers

All beta-blockers are potentially harmful in Brugada syndrome, unlike in other channelopathies where they may be beneficial 2

Other Medications and Substances

  • Anesthetic agents 1
  • Antihistamines 4
  • Cocaine 1, 4
  • Alcohol (excessive intake) 1, 2

Mechanism of Action

Most triggering medications work through one of these mechanisms:

  1. Sodium channel blockade - directly affects the already dysfunctional sodium channels in Brugada syndrome
  2. Alteration of autonomic tone - changes that promote the Brugada ECG pattern
  3. Other ion channel effects - affecting potassium or calcium currents that can worsen the underlying electrophysiological abnormality

Clinical Implications

Diagnostic Challenges

Sodium channel blockers (ajmaline, flecainide, procainamide) are deliberately used as provocative agents during diagnostic evaluation to reveal concealed Brugada patterns 1, 5. However, these challenges must be performed under careful monitoring, and the test should be terminated immediately if:

  • Ventricular arrhythmias develop
  • Marked QRS widening occurs
  • Type 1 Brugada ECG pattern emerges 1

Patient Safety Recommendations

  1. Patients should check medication safety on www.brugadadrugs.org before taking any new drugs 1, 2
  2. Prompt treatment of fever with antipyretic drugs is essential as fever can unmask Brugada ECG pattern and trigger arrhythmias 1, 2
  3. Avoid excessive alcohol intake and large meals 1, 2
  4. Isoproterenol can be used to treat electrical storms in Brugada syndrome 1, 2
  5. Quinidine may be considered for patients with recurrent ICD shocks or for treatment of supraventricular arrhythmias 1, 2

Pitfalls and Caveats

  • A drug-induced Brugada pattern doesn't always indicate true Brugada syndrome - further evaluation is needed 5
  • Incidental findings of Brugada pattern during medication administration (e.g., procainamide for atrial fibrillation) require cardiology referral 5
  • The relative potency of sodium channel blockers varies - ajmaline is more effective at unmasking Brugada pattern than flecainide (32% of patients may show negative response to flecainide but positive to ajmaline) 3
  • Patients with drug-induced Brugada pattern should be referred to cardiology for risk stratification even if the pattern resolves after medication discontinuation 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Brugada Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug-induced Brugada syndrome.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.